Haploidentical Hematopoietic Stem Cell Transplantation Clinical Trial
Official title:
Haploidentical Hematopoietic Stem Cell Transplantation With Early Antithymocyte Globulin and Low Dose Post-transplant Cyclophosphamide
Aim of this study is to investigate the effect of early administration of anti-thymocyte globulin and post-transplant low-dose cyclophosphamide in heploidentical hematopoietic stem cell transplantation.
Hematopoietic stem cell transplantation from a haploidentical donor (haplo-HCT) are increasingly used in patients lacking a matched donor, but the optimal strategy needs to be defined. This study aims to investigate the outcome of haplo-HCT with early antithymocyte globulin and low dose posttransplant cyclophosphamide (ATG/LD-PTCy) in a single center. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05622032 -
Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study
|
||
| Recruiting |
NCT06423131 -
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT
|
N/A | |
| Recruiting |
NCT02014506 -
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05166967 -
Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
|
Phase 4 | |
| Active, not recruiting |
NCT04778618 -
Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
|
Phase 2 | |
| Completed |
NCT03236220 -
Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation
|
Phase 2 | |
| Recruiting |
NCT06381817 -
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
|
Phase 3 |